National/Regional Resource Core: Accelerating Health Equity And Eliminating Diabetes Disparities in Community Health Centers (AHEAD-CHC)

项目摘要-国家/区域资源核心 国家核心的总体目标是促进社区以公平为中心的糖尿病翻译研究 健康中心（CHC）是美国弱势群体的主要流动护理系统。 建议的核心，题为加速健康公平和消除社区卫生中的糖尿病差异 中心（AHEAD-CHC），涉及全国三个最大和最有能力的CHC网络组织： 芝加哥联盟（Alliance）、健康选择网络（HCN）和中西部临床医生网络（MWCN）。 这些组织共同支持美国29个州的246个CHC站点，为约750万人提供服务 患者AHEAD-CHC还将与临床主任网络（CDN）合作开展传播活动 覆盖所有50个州的相关利益攸关方的全国受众。AHEAD-CHC利用以下优势 现有资产和关键基础设施，以成功实现这一国家核心的目标。在目标1中， 联盟和HCN将扩大现有的国家糖尿病数据库，目前包括100多万个 CHC患者，并将此资源提供给全国糖尿病翻译研究人员， CHC临床医生进行以权益为中心的分析。在目标2中，联盟、HCN和MWCN将提供一系列咨询服务， 支持糖尿病研究人员与CHC配对的合作服务，并帮助促进成功的 这些群体的实践研究。具体而言，AHEAD-CHC合作伙伴将利用现有基础设施 提供咨询，参加会议，并提供分析支持，以加速新的糖尿病翻译 在其CHC网络中进行的研究。在目标3中，AHEAD-CHC提供了一个全国性的传播机构， CDN将利用其现有的50，000多名研究人员，CHC工作人员和其他利益相关者 参加由核心基金会支持的糖尿病研究网络研讨会系列。然后，CDN会将网络研讨会存档在 AHEAD-CHC网站，沿着相关研究产品（如同行评审的出版物， 干预协议和白色文件），以便这些材料可以由无限的 观众凭借在社区卫生中心开展高影响力糖尿病研究的广泛集体经验， AHEAD-CHC领导团队的成员将研究结果转化为改善的糖尿病护理和结果， 是这一领域的国家主管部门，它们处于独特的地位，能够成功地开展拟议的工作。AHEAD-CHC 通过以下方式对RFA-DK-20-002做出高度响应：1）关注弱势群体、高风险群体和 社区卫生中心服务的人群; 2）提供促进整个研究工作的资源和服务 从建立伙伴关系到将研究成果转化为实践和政策的连续体; 3）加强 通过集中这些不同的资产并使其可从 一个单一的接入点;和4）证明建立了超越芝加哥糖尿病中心 翻译研究到美国所有50个州。

PROJECT SUMMARY - National/Regional Resource Core The overall goal of the national core is to catalyze equity-focused diabetes translation research in community health centers (CHC), the primary ambulatory system of care for vulnerable populations across the U.S. The proposed core, entitled Accelerating Health Equity And Eliminating Diabetes Disparities in Community Health Centers (AHEAD-CHC), engages three of the largest and most capable CHC network organizations nationwide: AllianceChicago (Alliance), Health Choice Network (HCN), and MidWest Clinicians' Network (MWCN). Collectively, these organizations support a total of 246 CHC sites across 29 U.S. states serving ~7.5 million patients. AHEAD-CHC will also partner with Clinical Directors Network (CDN) for dissemination activities reaching a national audience of relevant stakeholders in all 50 states. AHEAD-CHC leverages the following existing assets and critical infrastructure to accomplish the aims of this national Core successfully. In Aim 1, Alliance and HCN will expand an existing National Diabetes Data Repository that currently includes over 1 million CHC patients, and make this resource available to a national audience of diabetes translation researchers and CHC clinicians for equity-focused analyses. In Aim 2, Alliance, HCN, and MWCN will offer a range of consultative services to support collaborations pairing diabetes investigators with CHCs, and help catalyze successful practice-based research by these groups. Specifically, AHEAD-CHC partners will leverage existing infrastructure to offer consultations, participate in meetings, and provide analytic support to accelerate new diabetes translation research conducted in their CHC networks. In Aim 3, AHEAD-CHC offers a national dissemination arm led by CDN, which will leverage its existing audience of over 50,000 researchers, CHC staff, and other stakeholders for a webinar series featuring diabetes research supported by the Core. CDN will then archive the webinars on the AHEAD-CHC website, along with associated research products (e.g. peer-reviewed publications, intervention protocols, and white papers), so that these materials can be accessed on demand by an unlimited audience. With extensive collective experience conducting high-impact diabetes research in CHCs and then translating findings into improved diabetes care and outcomes, members of the AHEAD-CHC leadership team are national authorities in this area, who are uniquely positioned to succeed in the proposed work. AHEAD-CHC is highly responsive to RFA-DK-20-002 by: 1) focusing on health equity among the vulnerable, high-risk populations served by CHCs; 2) offering resources and services that catalyze work across the research continuum from partnership building to translation of research products into practice and policy; 3) enhancing efficiency, productivity, and effectiveness by centralizing these diverse assets and making them available from a single access point; and 4) demonstrating established reach beyond the Chicago Center for Diabetes Translation Research into all 50 U.S. states.